Early Stage Partners

What Early Stage Partners does

Early Stage Partners is a private venture capital firm founded in 2001 and headquartered in Cleveland, Ohio, with a secondary office in Cincinnati. The firm invests in early-stage healthcare and technology companies, primarily across the Midwest, serving founders building innovative products in medical devices, digital health, software, and adjacent technology markets. With an employee base of 11-50, it operates at the scale of a focused regional VC, sourcing and underwriting deals while providing active support to portfolio management teams.

The firm's portfolio includes HistoSonics, OnShift, Blue Spark Technologies, ShiftKey, and Arisdyne. Notable milestones include OnShift's $18M Series D in April 2016, a strategic investment in OnShift by Clearlake Capital in October 2018, a strategic investment in OnShift by ShiftKey in June 2022, a $102M funding round for HistoSonics in August 2024, and the $2.25B acquisition of HistoSonics in August 2025. Portfolio company Blue Spark Technologies has engaged Carnegie Mellon University on machine-learning/AI algorithm development, signaling exposure to AI-enabled healthcare/tech themes.

The firm's business model follows the standard venture capital construct: it raises limited-partner-funded vehicles, earns management fees during the investment period, and realizes carried interest from successful exits. Revenue is concentrated in fund management fees (typically 1.5-2% of committed capital) plus a share of profits from liquidity events such as the 2025 HistoSonics exit. Public AUM and fund-size disclosure is limited, which constrains precision around revenue scale.

Name

Early Stage Partners

Website

https://esplp.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Early Stage Partners is a Cleveland, Ohio-based venture capital firm founded in 2001 that invests in early-stage healthcare and technology companies, primarily across the Midwest United States.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

akta.pro secondary industries

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD), Late-Stage Venture Capital (Series C+) (FSANAAAC)

Keywords

• Early-stage venture capital
• Healthcare technology investing
• Medical device financing
• Portfolio investment management
• Venture capital partnerships

Headquarters

HQ city

Cleveland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Management Fees: VC firms typically charge management fees (usually 1.5-2% of assets under management) to cover operational expenses. Early Stage Partners likely charges management fees on committed capital from Limited Partners.
2. Carried Interest: VC firms earn carried interest (typically 20% of profits) when portfolio companies achieve successful exits. The HistoSonics $2.25B acquisition represents a potential carried interest event for ESP.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Early Stage Partners is a Midwest-based venture capital firm that raises capital from institutional Limited Partners and deploys it into early-stage healthcare and technology companies. The firm invests in sectors including medical devices, biotechnology, healthcare software, and industrial technology, providing portfolio companies with growth capital, board participation, and strategic guidance. Notable portfolio investments include HistoSonics, OnShift, Blue Spark Technologies, ShiftKey, Arisdyne, and Intelligent Clearing Network.

Product overview

Early Stage Partners is a venture capital firm that invests in early-stage healthcare and technology companies. The company does not offer its own products or services; instead, it serves as an investor in portfolio companies including HistoSonics (developer of the Edison Histotripsy System), OnShift (workforce management software for post-acute care), Blue Spark Technologies (TempTraq wearable temperature monitoring), ShiftKey (healthcare staffing marketplace platform), and other healthcare technology companies.

Differentiator

Problem solved

Functional benefit

Products and services

• Venture Capital Investment Funds Early-stage venture capital investment funds raised from institutional Limited Partners and deployed into early-stage healthcare and technology companies. The firm provides growth capital, board participation, and strategic guidance to portfolio companies in medical devices, biotechnology, healthcare software, and industrial technology sectors. Target customers are founders and executive teams of early-stage companies, as well as institutional investors serving as Limited Partners.

Quantifiable outcome

• $2.25B acquisition value for HistoSonics
• +2 more outcomes

Named customers6 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and flagship.

• General ElectriccoreTechnology or Integration · 15 August 2024GE provides diagnostic ultrasound technology used for tumor imaging in the HistoSonics Edison system. The system uses GE diagnostic ultrasound to image tumors before treatment delivery.
• ShiftKeyflagshipStrategic or Co-development Partner · 22 June 2022ShiftKey made a strategic investment in OnShift, combining ShiftKey's marketplace for healthcare professionals with OnShift's scheduling tools. The vision is to provide facilities with a holistic view of their workforce showing internal staff and independent workers in one place.
• OLS Payments (InComm Payments)coreStrategic or Co-development Partner · 23 February 2021OLS Payments partnered with Intelligent Clearing Network to provide cloud-based solutions for preventing paper coupon fraud. The solution is built on InComm Payments technology and the Enhanced Payment Platform.
• Intelligent Clearing Network (ICN)coreTechnology or Integration · 23 February 2021ICN provides patented, cloud-based coupon clearing services to address paper coupon fraud. The partnership with InComm Payments extends ICN's services to retailers using OLS Payments systems with minimal integration impact.
• Carnegie Mellon UniversitycoreStrategic or Co-development Partner · 19 January 2021Adam Perer, Assistant Research Professor at CMU's Human-Computer Interaction Institute, joined Blue Spark Technologies' TempTraq advisory board to develop predictive machine learning and AI algorithms for disease state prediction.
• United States Air Force Research Lab (AFRL)coreStrategic or Co-development Partner · 10 June 2020AFRL worked with Blue Spark Technologies to develop a TempTraq-compatible plug-in for BATDOK, enabling wireless temperature monitoring of military patients at point of injury.
• Archer Daniels Midland (ADM)coreStrategic or Co-development Partner · 26 April 2017ADM partnered with Arisdyne to jointly develop and commercialize new applications of cavitation technology for agricultural processing. ADM's Vice President noted they are 'evaluating next-generation process technologies' for process enhancements.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Wolverine Venture Fund: University of Michigan-affiliated early-stage fund that co-invested in HistoSonics alongside ESP. Comparable as a regionally focused early-stage healthcare/tech investor with university ecosystem ties.
• JumpStart Inc. Cleveland-based early-stage investor (including venture capital) focused on Northeast Ohio and Midwest healthcare/tech startups; co-invested in OnShift alongside ESP. Highly comparable as a regional early-stage VC with similar sector and geographic focus.
• Hatteras Venture Partners: Durham, NC-based early-stage healthcare VC that co-invested in HistoSonics across multiple rounds alongside ESP. Both firms focus on early-stage life sciences and healthcare technology, making them directly comparable on thesis, stage, and co-investment behavior.
• Glengary LLC: Midwest-based private investment firm co-investing in early-stage companies including OnShift alongside ESP. Comparable as a regional early-stage investor in the same geography and stage.
• HLM Venture Partners: Healthcare-focused early-to-growth stage VC that co-invested in OnShift alongside ESP. Comparable in healthcare vertical focus and early-stage investing orientation.
• Draper Triangle Ventures: Pittsburgh-based early-stage VC investing in healthcare, tech, and advanced materials; co-invested in OnShift alongside ESP. Directly comparable as a Midwest early-stage VC with similar stage and sector preferences.
• North Coast Venture Fund: Cleveland-area early-stage VC focused on tech-enabled healthcare and technology companies; co-invested in OnShift alongside ESP. Closely comparable on geography, stage, and sector thesis.
• Arboretum Ventures: Ann Arbor, Michigan-based early-stage healthcare VC investing in medical devices, healthcare IT, and services. Comparable as a Midwest early-stage healthcare specialist with similar stage and sector focus to ESP.
• TGap Ventures: Michigan-based early-stage VC investing in healthcare, technology, and life sciences; co-invested in HistoSonics alongside ESP. Comparable Midwest early-stage VC with overlapping healthcare/tech focus.

Broad incumbents

• Fifth Third Capital: Cincinnati-based corporate venture/growth capital arm of Fifth Third Bank that co-invested in OnShift alongside ESP. Comparable as a Midwest investor in early-stage healthcare/tech, though broader and part of a larger bank platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments41 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Early Stage Partners